The lipid-lowering effects of lomitapide are unaffected by adjunctive apheresis in patients with homozygous familial hypercholesterolaemia – A post-hoc analysis of a Phase 3, singl... von Stefanutti, C, Blom, D.J, Averna, M.R, Meagher, E.A, Theron, H. dT, Marais, A.D, Hegele, R.A, Sirtori, C.R, Shah, P.K, Gaudet, D, Vigna, G.B, Sachais, B.S, Di Giacomo, S, du Plessis, A.M.E, Bloedon, L.T, Balser, J, Rader, D.J, Cuchel, M

Volltext

Efficacy and safety of bempedoic acid in patients with heterozygous familial hypercholesterolemia: Analysis of pooled patient-level data from phase 3 clinical trials von Duell, P.B., Banach, M., Catapano, A.L., Laufs, U., Mancini, G.B.J., Ray, K.K., Bloedon, L.T., Ye, Z., Goldberg, A.C.

Volltext

J Am Coll Nutr: Flaxseed and cardiovascular risk factors: results from a double blind, randomized, controlled clinical trial von Bloedon, L.T, Balikai, S, Chittams, J

Volltext

The Effects of a Microsomal Triglyceride Transfer Protein Inhibitor on Fat Soluble Compounds von Bloedon, L.T, Cuchel, M, Santoroski, T, Sasiela, W, Rader, D.J

Volltext

Th-P16:322 Microsomial transfer protein (MTP) inhibition substantially reduces cholesterol in patients with homozygous familial hypercholesterolemia von Cuchel, M., Bloedon, L.T., Kolansky, D.M., Szapary, P.O., Wolfe, M.L., Millar, J.S., Ikewaki, K., Siegelman, E.S., Gregg, R.E., Rader, D.J.

Volltext

Guggulipid for the treatment of hypercholesterolemia. A randomized controlled trial von Szapary, P.O., Wolfe, M.L., Bloedon, L.T.

Volltext